Streptococcus pneumoniae is the leading cause of morbidity and mortality in developed as well as developing countries. Globally, pneumococcal infections have been estimated to cause 1.2 million deaths per year. Despite the use of appropriate antibiotics and intensive care, the case fatality rate of pneumococcal bacteremia has not changed in the past 40 years and remains at 15 to 40%. The pneumococcal polysaccharide (PPS) vaccine is fairly effective in young adults, however, a recent study showed that this vaccine reduced the risk of bacteremia by merely 44% in persons over 65 years of age. Recently, the pneumococcal conjugate vaccine was introduced and has proven highly efficacious against invasive disease in children<5 years of age. However, several studies have shown that the conjugate vaccines do not offer an advantage in immunogenicity over the conventional PPS vaccine in adults or the elderly. The reasons for these age- related differences in pneumococcal vaccine efficacy remain to be elucidated. An increased understanding of the relationship between anti-PPS antibody molecular structure and protective capacity would greatly benefit future pneumococcal vaccine and adjuvant design. We have generated an extensive library of PPS4 and PPS14 specific VH and VL chains obtained post-immunization from young and elderly adults. In addition, we have characterized the immune response of each volunteer by ELISA and opsonophagocytic activity. In this application we wish to further define and explore the potential correlation between antibody molecular structure, avidity and functional antibody activity in an effort to increase our understanding of the human immune response to PPS. 1 .We will test the hypothesis that aging affects the B cell clonotype and frequency of somatic mutation in the immune response to pneumococcal polysaccharides and that these changes result in altered antibody avidity and functional activity. This will be accomplished by: 1A. Developing human monoclonal antibodies by isolating, sorting and expanding single PPS responding B cells in vitro. The PPS-specific VH/VL will be cloned and sequenced. These studies will characterize the effect of aging on the molecular structure of PPS4, PPS14 and PPS23F specific antibodies in terms of B cell clonotype and somatic mutation. 1B. Cloning and expressing the paired variable regions obtained in Specific Aim 1A into identical Fab expression vectors. This strategy will allow us to assess influence of VH/VL molecular structure, independent of constant region, on affinity and fine specificity. 2. We will test the hypothesis that the nature of the IgG subclass (Fc) has a significant influence on avidity and function. We will construct human antibodies of the lgG1 and lgG2 subclasses containing identical VH and VL chains and define potential differences in avidity and investigate its molecular basis. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
2R01AG015978-06A2
Application #
7103256
Study Section
Special Emphasis Panel (ZRG1-IDM-K (02))
Program Officer
Fuldner, Rebecca A
Project Start
2000-04-01
Project End
2011-08-31
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
6
Fiscal Year
2006
Total Cost
$300,054
Indirect Cost
Name
University of Toledo
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
807418939
City
Toledo
State
OH
Country
United States
Zip Code
43614
Iyer, Anita S; Khaskhely, Noor M; Leggat, David J et al. (2016) Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults. PLoS One 11:e0150261
Iyer, Anita S; Ohtola, Jennifer A; Westerink, M A Julie (2015) Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic. Expert Rev Vaccines 14:85-97
Leggat, David J; Thompson, Rebecca S; Khaskhely, Noor M et al. (2013) The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells. J Infect Dis 208:101-8
Westerink, M A Julie; Schroeder Jr, Harry W; Nahm, Moon H (2012) Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination. Aging Dis 3:51-67
Khaskhely, Noor; Mosakowski, Jason; Thompson, Rebecca S et al. (2012) Phenotypic analysis of pneumococcal polysaccharide-specific B cells. J Immunol 188:2455-63
Rabquer, Bradley; Shriner, Anne K; Smithson, S Louise et al. (2007) B cell mediated priming following pneumococcal colonization. Vaccine 25:2036-42
Shriner, Anne K; Smithson, S Louise; Rabquer, Bradley et al. (2006) Analysis of the young and elderly variable gene repertoire in response to pneumococcal polysaccharides using a reconstituted SCID mouse model. Vaccine 24:7159-66
Shriner, Anne K; Smithson, S Louise; Prinz, Deborah M et al. (2006) Comparison of the human immune response to conjugate and polysaccharide pneumococcal vaccination using a reconstituted SCID mouse model. Vaccine 24:7197-203
Rabquer, Bradley; Smithson, S Louise; Shriner, Anne et al. (2006) The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination. Immunol Lett 106:187-90
Smithson, S Louise; Kolibab, Kris; Shriner, Anne K et al. (2005) Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable light chain repertoire. Infect Immun 73:7477-84

Showing the most recent 10 out of 11 publications